Dolby insider plans sale of 3,000 common shares

DOLBY LABORATORIES, INC.

Rhea-AI Filing Summary

DOLBY LABORATORIES, INC. (DLB) has a proposed sale of 3,000 shares of Common Stock through Morgan Stanley Smith Barney LLC Executive Financial Services, listed on the NYSE, with an aggregate value of $188,130.00 as of 08/14/2026.

The filing also lists restricted stock of 1,104 shares dated 05/16/2024 and 1,896 shares dated 12/15/2024 from the issuer, and discloses a prior sale of 3,000 Common shares for $164,700.00 on 05/15/2026 by Revankar.

Key Figures

Proposed shares to be sold: 3,000 shares Aggregate value of proposed sale: $188,130.00 Prior 3-month sale shares: 3,000 shares +3 more

6 metrics

Proposed shares to be sold 3,000 shares Common Stock proposed for sale through Morgan Stanley Smith Barney LLC Executive Financial Services

Aggregate value of proposed sale $188,130.00 Total value of 3,000 Common shares as of 08/14/2026

Prior 3-month sale shares 3,000 shares Common shares sold by Revankar on 05/15/2026

Prior 3-month sale value $164,700.00 Aggregate proceeds from Common shares sold on 05/15/2026

Restricted stock tranche 1 1,104 shares Restricted Stock dated 05/16/2024 from issuer

Restricted stock tranche 2 1,896 shares Restricted Stock dated 12/15/2024 from issuer

Key Terms

Form 144, restricted stock, Executive Financial Services, securities sold during the past 3 months

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock financial

"Common | 05/16/2024 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

securities sold during the past 3 months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Dolby Laboratories (DLB) report in this Form 144?

Dolby Laboratories (DLB) reports a proposed sale of 3,000 Common shares with an aggregate value of $188,130.00, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE as of 08/14/2026.

How many Dolby (DLB) shares are proposed to be sold and at what value?

The filing lists a proposed sale of 3,000 Common shares of Dolby at an aggregate value of $188,130.00. This amount represents the total dollar value associated with the shares indicated for potential sale as of 08/14/2026.

What prior sales are disclosed for Dolby (DLB) in the last 3 months?

The document discloses that Revankar sold 3,000 Common shares of Dolby on 05/15/2026 for total proceeds of $164,700.00. This transaction is reported under securities sold during the past three months.

What restricted stock positions are listed for Dolby (DLB) in this filing?

Two restricted stock positions are listed: 1,104 shares dated 05/16/2024 and 1,896 shares dated 12/15/2024, both identified as restricted stock from the issuer. These positions relate to Common Stock of Dolby.

Which intermediary is handling the proposed Dolby (DLB) share sale?

The proposed sale of 3,000 Common shares of Dolby is associated with Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as reflected in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:30 PM Accepted by SEC EDGAR 08/14/2026 - 04:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001928994
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOLBY LABORATORIES, INC.
SEC File Number	001-32431
Address of Issuer	1275 Market Street San Francisco CALIFORNIA 94103-1410
Phone	(415) 558-0200
Name of Person for Whose Account the Securities are To Be Sold	SHRIRAM REVANKAR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	188130.00	59416894	08/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/16/2024	Restricted Stock	ISSUER			1104	05/16/2024	Not Applicable
Common	12/15/2024	Restricted Stock	ISSUER			1896	12/15/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SHRIRAM REVANKAR 1275 Market Street San Francisco CA 94103-1410	Common	05/15/2026	3000	164700.00

144: Remarks and Signature

Remarks
Date of Notice	08/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/22/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shriram Revankar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)